Total Payments
$17,491
2024 Payments
$1,728
Companies
47
Transactions
491
Medicare Patients
3,727
Medicare Billing
$675,729
Payment Breakdown by Category
Food & Beverage$14,991 (85.7%)
Travel$2,500 (14.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,991 | 482 | 85.7% |
| Travel and Lodging | $2,500 | 9 | 14.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,426 | 166 | $0 (2024) |
| Boston Scientific Corporation | $3,775 | 82 | $0 (2024) |
| Nevro Corp. | $2,842 | 50 | $0 (2024) |
| Medtronic, Inc. | $838.94 | 8 | $0 (2024) |
| PAINTEQ LLC | $623.39 | 9 | $0 (2023) |
| Medtronic USA, Inc. | $433.91 | 15 | $0 (2019) |
| PFIZER INC. | $417.15 | 16 | $0 (2024) |
| Nuvectra Corporation | $385.65 | 5 | $0 (2018) |
| Gilead Sciences, Inc. | $320.37 | 17 | $0 (2021) |
| BioDelivery Sciences International, Inc. | $222.62 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,728 | 32 | Nevro Corp. ($696.49) |
| 2023 | $2,938 | 91 | Nevro Corp. ($1,117) |
| 2022 | $2,134 | 75 | Abbott Laboratories ($710.44) |
| 2021 | $1,495 | 64 | Abbott Laboratories ($486.57) |
| 2020 | $1,315 | 77 | Abbott Laboratories ($607.52) |
| 2019 | $3,101 | 76 | Boston Scientific Corporation ($2,143) |
| 2018 | $1,892 | 37 | BOSTON SCIENTIFIC CORPORATION ($676.59) |
| 2017 | $2,888 | 39 | Abbott Laboratories ($1,979) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $169.67 | General |
| Category: Drug Infusion Systems | ||||||
| 12/13/2024 | Medtronic, Inc. | ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: TL | ||||||
| 09/10/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $181.66 | General |
| Category: Drug Infusion Systems | ||||||
| 08/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $89.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/28/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $143.87 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/28/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $44.37 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Neuromodulation | ||||||
| 06/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neuromodulation | ||||||
| 05/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $144.60 | General |
| Category: Neuromodulation | ||||||
| 05/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $105.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: PAIN | ||||||
| 04/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| 04/18/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Neuromodulation | ||||||
| 04/04/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Neuromodulation | ||||||
| 03/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Neuromodulation | ||||||
| 03/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Neuromodulation | ||||||
| 03/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neuromodulation | ||||||
| 03/06/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $116.66 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Neuromodulation | ||||||
| 02/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 826 | 3,013 | $1.7M | $145,727 |
| 2022 | 19 | 829 | 3,275 | $1.9M | $133,957 |
| 2021 | 20 | 1,103 | 3,379 | $2.8M | $185,940 |
| 2020 | 24 | 969 | 1,548 | $3.1M | $210,104 |
Total Patients
3,727
Total Services
11,215
Medicare Billing
$675,729
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 13 | 26 | $135,200 | $37,887 | 28.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 53 | 72 | $331,800 | $16,489 | 5.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $54,800 | $12,972 | 23.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 77 | 78 | $154,647 | $11,970 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 97 | $35,599 | $9,671 | 27.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 17 | 26 | $127,218 | $9,157 | 7.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 17 | 35 | $70,140 | $7,145 | 10.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 38 | 56 | $81,900 | $5,980 | 7.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 19 | 29 | $102,950 | $5,522 | 5.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 26 | $124,088 | $5,515 | 4.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 37 | 48 | $100,800 | $4,461 | 4.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 11 | 15 | $37,125 | $3,131 | 8.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 14 | 25 | $46,063 | $2,801 | 6.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 25 | $126,000 | $2,624 | 2.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 17 | 20 | $52,800 | $2,619 | 5.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 19 | 23 | $18,400 | $2,169 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 27 | $8,910 | $1,512 | 17.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 113 | 117 | $23,400 | $1,434 | 6.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 23 | $35,000 | $1,321 | 3.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $6,000 | $849.90 | 14.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 26 | 33 | $825.00 | $295.18 | 35.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 102 | 2,100 | $10,500 | $202.39 | 1.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 59 | 120 | $504,000 | $26,104 | 5.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 89 | 90 | $180,000 | $13,893 | 7.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $55,348 | $12,202 | 22.0% |
About Dr. David Kim, MD
Dr. David Kim, MD is a Pain Medicine healthcare provider based in Cedar Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1205194560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kim, MD has received a total of $17,491 in payments from pharmaceutical and medical device companies, with $1,728 received in 2024. These payments were reported across 491 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($14,991).
As a Medicare-enrolled provider, Kim has provided services to 3,727 Medicare beneficiaries, totaling 11,215 services with total Medicare billing of $675,729. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Cedar Park, TX
- Active Since 04/24/2012
- Last Updated 12/09/2024
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1205194560
Products in Payments
- SPECTRA WAVEWRITER (Device) $1,963
- PROCLAIM (Device) $1,879
- Senza (Device) $1,813
- DRG leads (Device) $1,678
- PAINTEQ (Device) $623.39
- Omnia (Device) $622.90
- INFINION (Device) $545.24
- Proclaim IPG (Device) $427.39
- Senza Spinal Cord Stimulation System (Device) $405.63
- Proclaim Family of SCS IPGs (Device) $400.22
- Algovita (Device) $385.65
- SYNCHROMEDII (Device) $351.33
- RESTORE (Device) $333.99
- GENERAL PAIN MANAGEMENT (Device) $333.48
- LYRICA (Drug) $308.63
- GENERAL PAIN MANAGEMENT (Device) $279.85
- Proclaim Plus SCS with FlexBurst360 (Device) $202.18
- NURTEC ODT (Drug) $196.49
- Aimovig (Biological) $192.88
- VANTA ADAPTIVESTIM (Device) $189.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.